Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Suzanne Kay Freitag, M.D.


This page shows the publications Suzanne Freitag has written about Eyelid Neoplasms.
Connection Strength

  1. Sentinel Lymph Node Biopsy for Eyelid and Conjunctival Malignancy: A Report by the American Academy of Ophthalmology. Ophthalmology. 2020 12; 127(12):1757-1765.
    View in: PubMed
    Score: 0.757
  2. Dermatofibroma of the Eyelid: Immunohistochemical Diagnosis. Ophthalmic Plast Reconstr Surg. 2017 Nov/Dec; 33(6):e134-e138.
    View in: PubMed
    Score: 0.627
  3. Primary cutaneous extranodal marginal zone B-cell lymphoma of the eyelid skin: Diagnostic clues and distinction from other ocular adnexal diseases. Surv Ophthalmol. 2016 May-Jun; 61(3):333-8.
    View in: PubMed
    Score: 0.546
  4. Controversies in Sentinel Lymph Node Biopsy for Ocular Neoplasms. Int Ophthalmol Clin. 2015; 55(4):73-9.
    View in: PubMed
    Score: 0.516
  5. The role of genetics in the pathogenesis of periocular cutaneous neoplasms: implications for targeted therapy. Semin Ophthalmol. 2013 Sep-Nov; 28(5-6):267-74.
    View in: PubMed
    Score: 0.470
  6. Metastasis to eyelid as initial presentation of non-small cell carcinoma. Ophthalmic Plast Reconstr Surg. 2009 Sep-Oct; 25(5):406-8.
    View in: PubMed
    Score: 0.356
  7. Advances in Immunotherapy and Periocular Malignancy. Semin Ophthalmol. 2019; 34(4):327-333.
    View in: PubMed
    Score: 0.175
  8. Nodulo-Ulcerative Ocular Surface Squamous Neoplasia in 6 Patients: A Rare Presentation. Cornea. 2017 Mar; 36(3):322-326.
    View in: PubMed
    Score: 0.150
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.